Clinical Trial Update: Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining tirzepatide for reversing lipotoxicity and adipose tissue dysfunction in adults with overweight or obesity, currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Stanford University | Conditions: Obesity, Overweight and Obesity | Phase 2 | Status: RECRUITING